J.K. Mellon
- Molecular Biology
- Cancer Research top 10%
- Oncology
- Surgery
- Cell Biology top 10%
- Co-authors
- T.R. Leyshon GriffithsJohn LunecJ E NuttRicky A. SharmaP. RajjayabunEugene TulchinskyMarina KriajevskaW.P. Steward
- Topics
- Bladder and Urothelial Cancer Treatments (5 papers)Peptidase Inhibition and Analysis (3 papers)Protease and Inhibitor Mechanisms (3 papers)
- Partner nations
- United KingdomAustraliaDenmark
In The Last Decade
J.K. Mellon
20 papers receiving 715 citations
Peers
Comparison fields: 5 of 87
- Molecular Biology 380
- Cancer Research 216
- Oncology 168
- Surgery 161
- Cell Biology 120
Countries citing papers authored by J.K. Mellon
This map shows the geographic impact of J.K. Mellon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.K. Mellon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.K. Mellon more than expected).
Fields of papers citing papers by J.K. Mellon
This network shows the impact of papers produced by J.K. Mellon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.K. Mellon. The network helps show where J.K. Mellon may publish in the future.
Co-authorship network of co-authors of J.K. Mellon
This figure shows the co-authorship network connecting the top 25 collaborators of J.K. Mellon. A scholar is included among the top collaborators of J.K. Mellon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.K. Mellon. J.K. Mellon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 86 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 91 | |
| 6 | 18 | |
| 7 | 103 | |
| 8 | 9 | |
| 9 | 2 | |
| 10 | 14 | |
| 11 | 7 | |
| 12 | 69 | |
| 13 | 35 | |
| 14 | 24 | |
| 15 | 98 | |
| 16 | Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder. | 37 |
| 17 | 36 | |
| 18 | 78 | |
| 19 | 6 | |
| 20 | 3 |
About J.K. Mellon
J.K. Mellon is a scholar working on Cancer Research, Biochemistry and Urology, having authored 20 papers that have together received 731 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (5 papers), Peptidase Inhibition and Analysis (3 papers) and Protease and Inhibitor Mechanisms (3 papers). The work is most often cited by research in Cancer Research (216 citations), Immunology and Allergy (49 citations) and Cell Biology (120 citations). J.K. Mellon has collaborated with scholars based in United Kingdom, Australia and Denmark. Frequent co-authors include T.R. Leyshon Griffiths, John Lunec, J E Nutt, Ricky A. Sharma, P. Rajjayabun, Eugene Tulchinsky, Marina Kriajevska, W.P. Steward, A. Gescher and Mary Robinson. Their work appears in journals such as Oncogene, The Journal of Urology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.